These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 6141175

  • 1. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
    Lamberts SW, Verleun T, Oosterom R.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
    [Abstract] [Full Text] [Related]

  • 2. Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro.
    Silverman BL, Bettendorf M, Kaplan SL, Grumbach MM, Miller WL.
    Endocrinology; 1989 Jan; 124(1):84-9. PubMed ID: 2562828
    [Abstract] [Full Text] [Related]

  • 3. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries.
    Goodyer CG, Branchaud CL, Lefebvre Y.
    J Clin Endocrinol Metab; 1993 May; 76(5):1259-64. PubMed ID: 8098715
    [Abstract] [Full Text] [Related]

  • 4. In vitro modulation of growth hormone (GH) secretion from early to midgestation human fetal pituitaries by GH-releasing factor and somatostatin: role of Gs-adenylate cyclase-Gi complex and Ca2+ channels.
    Goodyer CG, Branchaud CL, Lefebvre Y.
    J Clin Endocrinol Metab; 1993 May; 76(5):1265-70. PubMed ID: 8098716
    [Abstract] [Full Text] [Related]

  • 5. Physiological role of growth hormone (GH)-releasing factor and somatostatin in the dynamics of GH secretion in adult male rat.
    Sato M, Takahara J, Fujioka Y, Niimi M, Irino S.
    Endocrinology; 1988 Oct; 123(4):1928-33. PubMed ID: 2901340
    [Abstract] [Full Text] [Related]

  • 6. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
    Cuttler L, Welsh JB, Szabo M.
    Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
    [Abstract] [Full Text] [Related]

  • 7. In vitro regulation of growth hormone (GH) release from ovine pituitary cells during fetal and neonatal development: effects of GH-releasing factor, somatostatin, and insulin-like growth factor I.
    Blanchard MM, Goodyer CG, Charrier J, Barenton B.
    Endocrinology; 1988 May; 122(5):2114-20. PubMed ID: 2896119
    [Abstract] [Full Text] [Related]

  • 8. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion.
    Tannenbaum GS, Ling N.
    Endocrinology; 1984 Nov; 115(5):1952-7. PubMed ID: 6149116
    [Abstract] [Full Text] [Related]

  • 9. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
    Tannenbaum GS, Painson JC, Lengyel AM, Brazeau P.
    Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
    [Abstract] [Full Text] [Related]

  • 10. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME, Tyler JM, Farmer PK.
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [Abstract] [Full Text] [Related]

  • 11. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW.
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [Abstract] [Full Text] [Related]

  • 12. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D, Bruno JF, Wood TL, Gelato MC, Leidy JW, Gilbert JM, Berelowitz M.
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [Abstract] [Full Text] [Related]

  • 13. Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues.
    Chihara K, Iwasaki J, Minamitani N, Kaji H, Matsukura S, Tamaki N, Matsumoto S, Fujita T.
    J Clin Endocrinol Metab; 1982 Apr; 54(4):773-9. PubMed ID: 6120948
    [Abstract] [Full Text] [Related]

  • 14. Calcium homeostasis in growth hormone (GH)-secreting adenoma cells: effect of GH-releasing factor.
    Dufy-Barbe L, Bresson L, Sartor P, Odessa MF, Dufy B.
    Endocrinology; 1992 Sep; 131(3):1436-44. PubMed ID: 1505473
    [Abstract] [Full Text] [Related]

  • 15. Effects of growth hormone-releasing factor (1-44) on growth hormone release from human somatotrophinomas in vitro: interaction with somatostatin, dopamine, vasoactive intestinal peptide and cycloheximide.
    White MC, Daniels M, Kendall-Taylor P, Turner SJ, Mathias D, Teasdale G.
    J Endocrinol; 1985 May; 105(2):269-76. PubMed ID: 2859345
    [Abstract] [Full Text] [Related]

  • 16. Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin.
    Holl RW, Thorner MO, Leong DA.
    Endocrinology; 1988 Jun; 122(6):2927-32. PubMed ID: 2453353
    [Abstract] [Full Text] [Related]

  • 17. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells.
    Fukata J, Diamond DJ, Martin JB.
    Endocrinology; 1985 Aug; 117(2):457-67. PubMed ID: 2862007
    [Abstract] [Full Text] [Related]

  • 18. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
    Painson JC, Tannenbaum GS.
    Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
    [Abstract] [Full Text] [Related]

  • 19. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [Abstract] [Full Text] [Related]

  • 20. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.